|
| Exchange Received Time 12/07/2018 17:24:49 Exchange Disseminated Time 12/07/2018 17:24:52 Time Taken 00:00:03 | This letter has a reference to a newspaper publication in 'Mint' on July 12, 2018 regarding issuance of a show cause notice by drug licensing authority to Themis Medicare Limited (Themis), who is a manufacturer of Diclofenac 1 ml injection for Novartis India Limited (Company).
In this context, it may be noted that Themis has intimated the Company on July 12, 2018 that they are in receipt of a show cause notice dated July 11, 2018 from the drug licensing authority at Daman, wherein they were directed to not manufacture the said product until the matter is decided. (contd..)
|
|
|